Skip to content



PAHO/WHO’s strategic goal of technical cooperation in this area is to support countries in attaining “Equitable Access to essential medical products and technologies of assured quality, safety and efficacy, cost effectiveness, and on their sound and cost-effective use”.

Caribbean countries known as Small Islands Development States (SIDS) have several commonalities, including high public and private expenditure on medicines and challenges for regulation and enforcement and guaranteeing quality and safety of medicines.  This expose the population to treats like counterfeit or falsified and/or sub-standard medicines among other problems.

In the Caribbean, the overall objective of the technical cooperation is improving availability, affordability and rational use of quality and safe medicines in the Caribbean, in order to contribute for the achievement of the Millennium Development Goals (MDG)  related to health in the Caribbean countries, namely, acute and non-communicable diseases (MDG 8); reduce child mortality (MDG 4), improve women's health (MDG 5) and lower the burden of HIV/AIDS, malaria, tuberculosis and other diseases (MDG 6).

 
 

 

 

 

 

 

 

 

Last Updated on Friday, 25 July 2014 13:54
 

 

Bioequivalence  

Biotechnological Products

Counterfeit medicines

Good Clinical Practices

Good Laboratory Practices

Good Manufacturing Practices

Medical Plants

Medicines Classification 

Medicines Promotion

Medicines Registration

Pharmacopoeia 

Pharmacovigilance

Vaccines

Regional Office for the Americas of the World Health Organization
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America
Tel.: +1 (202) 974-3000 Fax: +1 (202) 974-3663

© Pan American Health Organization. All rights reserved.